Experienced in Lung Metastases

Dr. Mehdi S. Mirsaeidi

Pulmonary Medicine
University Of Florida Jacksonville Physicians, Inc.
15255 Max Leggett Pkwy, Suite 3600, 
Jacksonville, FL 
Accepting New Patients
Experienced in Lung Metastases
University Of Florida Jacksonville Physicians, Inc.
15255 Max Leggett Pkwy, Suite 3600, 
Jacksonville, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Mehdi Mirsaeidi is a Pulmonary Medicine provider in Jacksonville, Florida. Dr. Mirsaeidi is rated as an Experienced provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Sarcoidosis, Neurosarcoidosis, Lymphofollicular Hyperplasia, Mycobacterium Avium Complex Infections, and Lung Transplant. Dr. Mirsaeidi is currently accepting new patients.

His clinical research consists of co-authoring 195 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pulmonary Medicine
Licenses
Internal Medicine in FL
Hospital Affiliations
Shands Jacksonville
Languages Spoken
English
Farsi
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

UNIVERSITY OF FLORIDA JACKSONVILLE PHYSICIANS, INC.
15255 Max Leggett Pkwy, Suite 3600, Jacksonville, FL 32218
Other Locations
UNIVERSITY OF FLORIDA JACKSONVILLE PHYSICIANS, INC.
10475 Centurion Pkwy N, Suite 201, Jacksonville, FL 32256
UNIVERSITY OF FLORIDA JACKSONVILLE PHYSICIANS, INC.
653 W 8th St, Jacksonville, FL 32209
UNIVERSITY OF FLORIDA JACKSONVILLE PHYSICIANS, INC.
655 W 8th St, Jacksonville, FL 32209

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Ph. 2, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety, & Tolerability of Oral Omadacycline in Adults With NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex
A Ph. 2, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety, & Tolerability of Oral Omadacycline in Adults With NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex
Enrollment Status: Completed
Publish Date: July 30, 2025
Intervention Type: Drug
Study Phase: Phase 2
Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease
Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease
Enrollment Status: Active_not_recruiting
Publish Date: December 04, 2024
Intervention Type: Drug
Study Drugs: Azithromycin, Ethambutol, Rifampin
Study Phase: Phase 2/Phase 3
A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Safety and Efficacy of ATYR1923 In Adult Patients With Severe Pneumonia Related to SARS-CoV-2 Infection (COVID-19)
A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Safety and Efficacy of ATYR1923 In Adult Patients With Severe Pneumonia Related to SARS-CoV-2 Infection (COVID-19)
Enrollment Status: Completed
Publish Date: August 18, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Two-Stage, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of OP-101 (Dendrimer N-acetyl-cysteine) in Patients With Severe COVID-19
A Two-Stage, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of OP-101 (Dendrimer N-acetyl-cysteine) in Patients With Severe COVID-19
Enrollment Status: Terminated
Publish Date: February 13, 2023
Intervention Type: Drug
Study Drug: OP-101
Study Phase: Phase 2
Outcome Study of Sarcoidosis: a New Paraneoplastic Syndrome in Patient With Cancer
Outcome Study of Sarcoidosis: a New Paraneoplastic Syndrome in Patient With Cancer
Enrollment Status: Completed
Publish Date: May 04, 2022
A Randomized, Double-blind Study to Evaluate the Safety, Tolerability, and Potential Efficacy of BACTELIDE vs. Placebo in Addition to Standard-of-care Therapy for S. Aureus, P. Aeruginosa, and K. Pneumoniae Colonized Pressure Injuries
A Randomized, Double-blind Study to Evaluate the Safety, Tolerability, and Potential Efficacy of BACTELIDE vs. Placebo in Addition to Standard-of-care Therapy for S. Aureus, P. Aeruginosa, and K. Pneumoniae Colonized Pressure Injuries
Enrollment Status: Unknown
Publish Date: December 21, 2021
Intervention Type: Combination product, Procedure
Study Phase: Phase 1/Phase 2
View 5 Less Clinical Trials

194 Total Publications

Metabolomics and Cytokine Signatures in COVID-19: Uncovering Immunometabolism in Pathogenesis.
Metabolomics and Cytokine Signatures in COVID-19: Uncovering Immunometabolism in Pathogenesis.
Journal: Metabolites
Published: August 03, 2025
Similar Doctors
Distinguished in Lung Metastases
Dr. Maria B. Antonio-Miranda
Pulmonary Medicine
Distinguished in Lung Metastases
Dr. Maria B. Antonio-Miranda
Pulmonary Medicine
1665 Kingsley Ave, Suite 107, 
Orange Park, FL 
 (22.8 miles away)
904-269-9200
Languages Spoken:
English, Filipino, Spanish
See accepted insurances
Accepting New Patients

Maria Antonio-Miranda is a Pulmonary Medicine provider in Orange Park, Florida. Dr. Antonio-Miranda is rated as a Distinguished provider by MediFind in the treatment of Lung Metastases. Her top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Atypical Pneumonia, Hospital-Acquired Pneumonia, and Advanced Bronchoscopy. Dr. Antonio-Miranda is currently accepting new patients.

Distinguished in Lung Metastases
Dr. Alexis A. Vazquez
Pulmonary Medicine | Intensive Care Medicine
Distinguished in Lung Metastases
Dr. Alexis A. Vazquez
Pulmonary Medicine | Intensive Care Medicine
1361 13th Ave S, Suite 245, 
Jacksonville Beach, FL 
 (20.1 miles away)
904-493-7174
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Alexis Vazquez is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Jacksonville Beach, Florida. Dr. Vazquez is rated as a Distinguished provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Lung Nodules, Gastrostomy, and Myringotomy. Dr. Vazquez is currently accepting new patients.

Distinguished in Lung Metastases
Dr. Stuart Z. Millstone
Pulmonary Medicine
Distinguished in Lung Metastases
Dr. Stuart Z. Millstone
Pulmonary Medicine
1893 Kingsley Ave, Ste C, 
Orange Park, FL 
 (22.9 miles away)
904-276-2044
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Stuart Millstone is a Pulmonary Medicine provider in Orange Park, Florida. Dr. Millstone is rated as a Distinguished provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Pleurisy, and Pleural Effusion. Dr. Millstone is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mirsaeidi's expertise for a condition
ConditionClose
View All 18 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile